chr6-110209092-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_015891.3(CDC40):c.499G>A(p.Val167Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000778 in 1,542,508 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015891.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CDC40 | NM_015891.3 | c.499G>A | p.Val167Ile | missense_variant | 5/15 | ENST00000307731.2 | |
CDC40 | XM_047418862.1 | c.-237G>A | 5_prime_UTR_variant | 3/13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CDC40 | ENST00000307731.2 | c.499G>A | p.Val167Ile | missense_variant | 5/15 | 1 | NM_015891.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000532 AC: 8AN: 150308Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000169 AC: 4AN: 237344Hom.: 0 AF XY: 0.00000778 AC XY: 1AN XY: 128554
GnomAD4 exome AF: 0.00000216 AC: 3AN: 1392090Hom.: 0 Cov.: 27 AF XY: 0.00000144 AC XY: 1AN XY: 694756
GnomAD4 genome AF: 0.0000598 AC: 9AN: 150418Hom.: 0 Cov.: 32 AF XY: 0.0000818 AC XY: 6AN XY: 73316
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 11, 2023 | The c.499G>A (p.V167I) alteration is located in exon 5 (coding exon 5) of the CDC40 gene. This alteration results from a G to A substitution at nucleotide position 499, causing the valine (V) at amino acid position 167 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at